Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tezepelumab for reducing oral corticosteroid use in adults with oral corticosteroid–dependent asthma has completed, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2021-12-09